TYROSINE KINASE INHIBITORS
Taxotere is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat locally advanced or metastatic breast cancer after chemotherapy hasn’t worked. Taxotere is also approved to treat non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcinoma, and squamous cell carcinoma of the head and neck. Taxotere is also referred to by its drug name, docetaxel.
Taxotere is a HER2 receptor antagonist and tyrosine kinase inhibitor. Taxotere is believed to work by preventing cancer cells from multiplying.
How do I take it?
Prescribing information states that Taxotere is administered intravenously every three weeks.
Taxotere comes in the form of an intravenous infusion.
The FDA-approved label for Taxotere lists common side effects including low blood cell counts, susceptibility to infection, fluid retention, allergic reactions, hair loss, numbness in the fingers and toes, nausea, vomiting, constipation, taste changes, fatigue, muscle pain, nail changes, and mouth or throat sores.
Rare but serious side effects listed for Taxotere include other cancers, severe skin reactions, impaired sensory perception, weakness, fluid buildup in the eye, tumor lysis syndrome (a condition in which dead cancer cells are released into the blood too quickly), and fetal harm in pregnant women.
For more details about this treatment, visit:
Taxotere — BreastCancer.org
Taxotere — RxList